EBI-005: Clinical Trials

2 trials of EBI-005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow EBI-005: new trials by email Literature Review of EBI-005 trials Research Report on EBI-005

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
EBI-005, Placebo Comparator - Allergic Conjunctivitis (AC)
Phase 3CompletedEleven Biotherapeutics2502015-07-012016-02-11
Study of EBI-005 in Dry Eye Disease (DED)
EBI-005, Placebo - Dry Eye
Phase 3UnknownEleven Biotherapeutics1882015-04-012015-06-04

Conditions studied

Conjunctivitis, Allergic (1)  ·  Disease (1)  ·  Dry Eye Syndromes (1)

Sponsors

Eleven Biotherapeutics (2)

Countries

United States (2)

Top investigators

Michael Goldstein, MD (2)